Vioxx (rofecoxib) just got approved in the U.S. for migraines and Health Canada is considering the same

May 2004

Vioxx (rofecoxib) just got approved in the U.S. for migraines and Health Canada is considering the same.

It's the first COX-2 inhibitor approved for this use.

This is not a surprise.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter Canada includes:

12 issues every year, with brief articles about new meds and hot topics
200+ CE courses, including the popular CE-in-the-Letter
Quick reference drug comparison charts
Access to the entire archive

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get quote

Table of Contents

You'll see fewer children get antibiotics for ear infections
antidepressants might lead to suicide in BOTH CHILDREN AND ADULTS
Cardiology Tylenol ads that caution about taking ibuprofen with ASA
Cholesterol People often ask how they can increase their HDL cholesterol
Pediatrics Oral and IV Cipro can be used in CHILDREN
Ophthalmology dietary supplements to try to prevent or slow the progression of macular degeneration
Dermatology Aldara is being used for actinic keratoses
Dermatology some drugs make patients more sensitive to the sun
Hematology & Oncology Neulasta for chemo patients in Canada
Infectious Diseases Syphilis cases are up, and there's confusion over therapies
Lots of drug study results are being disseminated with a favourable spin
Migraine Vioxx (rofecoxib) just got approved in the U.S. for migraines and Health Canada is considering the same